Cancer Center AssociatesMar 8, 20212 minFDA Approves Libtayo for NSCLC With High PD-L1 ExpressionLibtayo is now approved for the first-line treatment of patients. Call our team at 972-548-9690 to see if this treatment is right for you.
Dr. Amanullah Khan MDMar 8, 20211 minTAGRISSO- New Indications for Non Small Cell Lung Cancer!New treatment options for resectable EGFRm Non-Small Cell Lung Cancer—Tagrisso: Convenient, once-daily dosing, taken at home.
Dr. Farhan Mohammad MDSep 23, 20201 minAcute promyelocytic leukemia (APL) in a patient with Crohn's disease and exposure to infliximab: a A very rare and possibly one of the few case reports of acute promyelocytic leukemia (APL; acute myeloid leukemia M3, AML-M3) to be reported
Dr. Farhan Mohammad MDSep 23, 20203 minComposite Diffuse Large B-cell and Mantle Cell Lymphoma: A Case ReportComposite lymphoma is an extremely rare clinical entity.